Company / Free Cash Flow per Share
Amneal Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.53
FY2025
5-year range
-$0.34 / $1.61
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
#40 of 192
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s free cash flow per share of $1.53 is higher than 79% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-0.34 in FY2021 to $139416.00 in FY2017.
Based on SEC 10-K filings.
1.53 in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Improved from $1.28 to $1.53 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +130.3%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
+107.7% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 4.9% year-over-year.
- Ranks #40 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.53 | -4.9% |
| FY2024 | $1.61 | +26.0% |
| FY2023 | $1.28 | +918.4% |
| FY2022 | $0.13 | +136.5% |
| FY2021 | -$0.34 | -126.2% |
| FY2020 | $1.31 | +19.9% |
| FY2019 | $1.10 | +1911.5% |
| FY2018 | -$0.06 | -100.0% |
| FY2017 | $139416.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026